Deciphera Pharmaceuticals said on Monday Japan’s Ono Pharmaceutical Co will acquire the cancer drugmaker for $2.4 billion to expand its oncology portfolio and presence in the United States and Europe. Ono Pharma...
PE Advent International queues up for a stake in Apollo 24/7
US private equity fund Advent International is among investors in discussions to acquire a minority stake in Apollo 24/7, the digital healthcare platform of Apollo Hospitals, said two people aware of the development...
M&A deal value soars 60% to $19.6 billion with net 455 in Q1FY25, PE dips slightly: PwC India
The overall merger and acquisition (M&A) deal value soared by 60 per cent to $19.6 billion in January-March 2024, while that of the private equity (PE) ones experienced a slight dip, according to a latest PwC India...
Advent International to combine its listed & private entity business
Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company. Advent being one of the largest private equity entities, is the merger move looking...
ChrysCap buys small stake in generics company La Renon for Rs 600 cr
The homegrown PE fund ChrysCapital has invested about Rs 600 crore ($70 million) in Ahmedabad-based La Renon Healthcare, valuing it at $800 million. ChrysCap has acquired about 8% stake from the promoter family in a...
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to $1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease. The maker of hit...
AstraZeneca to buy fusion for $2 billion
AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals for $2 billion in cash as the drugmaker bets on next-generation cancer treatments. The deal gives AstraZeneca a foothold in the...
Suven Pharma, Cohance Lifesciences to merge to bolster CDMO business
Suven Pharmaceuticals Ltd and Cohance Lifesciences Ltd signed a definitive agreement to merge their businesses, which will further strengthen the former’s position in the contract development and manufacturing...
KKR considers selling stake in India’s $3 billion JB Pharma
KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter. The US...
Brookfield, GIC, Alpha Wave eye Blackstone company PGP Glass
Brookfield, GIC of Singapore, the country’s sovereign wealth fund and Alpha Wave are circling around PGP Glass Pvt Ltd (formerly called Piramal Glass) for a minimum 50% stake along with joint control as Blackstone the...
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
GSK said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions. GSK will pay $1 billion upfront and up to $400 million...
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the company said late on...